Cargando…

Editorial: Influenza and related viruses: Epidemiology, pathogenesis, and therapeutics

Detalles Bibliográficos
Autores principales:	Asha, Kumari, Meseko, Clement, Kumar, Binod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846121/ https://www.ncbi.nlm.nih.gov/pubmed/36660434 http://dx.doi.org/10.3389/fmolb.2022.1117067

Ejemplares similares

PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection
por: Lekshmi, V. S., et al.
Publicado: (2023)

Editorial: Exploring circular RNAs and their applications within health and disease
por: Becatti, Matteo, et al.
Publicado: (2023)

The emerging influenza virus threat: status and new prospects for its therapy and control
por: Kumar, Binod, et al.
Publicado: (2018)

Editorial: Fibrotic tissue remodeling as a driver of disease pathogenesis
por: Basak, Trayambak, et al.
Publicado: (2023)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
por: Dasari, Subramanyam, et al.
Publicado: (2023)

Editorial: Primary cilia as therapeutic targets
por: Nishimura, Yuhei, et al.
Publicado: (2023)

Editorial: Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease
por: Bharadwaj, Shiv, et al.
Publicado: (2023)

Editorial: Exosomal biomarkers: Roles in diagnostics and therapeutics
por: Gupta, Dwijendra K.
Publicado: (2023)

Editorial: Insights in molecular diagnostics and therapeutics: 2022
por: Becatti, Matteo, et al.
Publicado: (2023)

Editorial: The DNA Replication Machinery as Therapeutic Targets
por: Gardner, Andrew F., et al.
Publicado: (2019)

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics
por: Luo, Na
Publicado: (2022)

Editorial: Insights in molecular diagnostics and therapeutics: 2021
por: Becatti, Matteo, et al.
Publicado: (2022)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
por: Milutinovic, Bojana, et al.
Publicado: (2022)

Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
por: Kenny, Grace, et al.
Publicado: (2023)

Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19
por: Chatterjee, Swapan K., et al.
Publicado: (2020)

Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections
por: Asha, Kumari, et al.
Publicado: (2018)

Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
por: Suraweera, Amila, et al.
Publicado: (2022)

Editorial: Targeting glioblastoma: Mechanisms of pathology and novel therapeutic strategies
por: Kusaczuk, Magdalena, et al.
Publicado: (2023)

Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics
por: Shi, Rongchen, et al.
Publicado: (2023)

Editorial: Emerging 3D and Animal Models in Diseases and Therapeutics
por: Teng, Yong, et al.
Publicado: (2022)

Editorial: The role of the extracellular matrix in tumor progression and therapeutic resistance
por: Vishnoi, Monika, et al.
Publicado: (2022)

Editorial: Advances in Alzheimer’s disease diagnostics, brain delivery systems, and therapeutics
por: Iyaswamy, Ashok, et al.
Publicado: (2023)

Editorial: RNA Diseases in Humans—From Fundamental Research to Therapeutic Applications
por: Kataoka, Naoyuki, et al.
Publicado: (2019)

Editorial: Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases
por: Sun, Leming, et al.
Publicado: (2022)

Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence
por: Khan, Abbas, et al.
Publicado: (2022)

Editorial: Scanning Probe Microscopies and Related Methods in Biology
por: Engel, Andreas, et al.
Publicado: (2021)

Editorial: The Upcoming Complications of COVID-19 on Recovered Patients: Molecular Mechanisms and Therapeutic Opportunities
por: Jahanban-Esfahlan, Rana, et al.
Publicado: (2022)

Editorial: Oxidative stress in degenerative bone and joint diseases: novel molecular mechanisms and therapeutic potential
por: Lin, Jialiang, et al.
Publicado: (2023)

A cell free biomembrane platform for multimodal study of influenza virus hemagglutinin and for evaluation of entry-inhibitors against hemagglutinin
por: Roy, Arpita, et al.
Publicado: (2022)

Editorial: The upcoming complications of COVID-19 on recovered patients: molecular mechanisms and therapeutic opportunities, volume II
por: Seradj, Seyed Hassan, et al.
Publicado: (2023)

Editorial: Recent Advances in In Vitro and In Vivo Multi-Omics Analyses of Extracellular Vesicles: Therapeutic Targets and Biomarkers
por: Manfredi, Marcello, et al.
Publicado: (2021)

Editorial: Heterogeneity and plasticity of prostate cancer
por: Culig, Zoran, et al.
Publicado: (2023)

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
por: Kumar, Vinay, et al.
Publicado: (2023)

Editorial: The Role of Epithelial-Mesenchymal Transition-Related Non-Coding RNAs in Cancer
por: Cao, Rui, et al.
Publicado: (2022)

Impact of the Host-Microbiome on Osteomyelitis Pathogenesis
por: Chen, Jun, et al.
Publicado: (2021)

Matrin3: Disorder and ALS Pathogenesis
por: Salem, Ahmed, et al.
Publicado: (2022)

Critical Involvement of TFIIB in Viral Pathogenesis
por: O’Brien, Michael J., et al.
Publicado: (2021)

Inflammasomes and their roles in arthritic disease pathogenesis
por: Yang, Gabsik, et al.
Publicado: (2022)

Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
por: Dhama, Kuldeep, et al.
Publicado: (2019)

Editorial: Investigating the impact of bioactive metabolites and extracts in human health and disease
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_npdrkv0l2u69rmpl2ckfrevdct